about
Hydrogen sulfide chemical biology: pathophysiological roles and detectionIs there a role for ischaemic conditioning in cardiac surgery?Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.Cardiac resynchronization by cardiosphere-derived stem cell transplantation in an experimental model of myocardial infarction.Changes in the myocardial interstitium and contribution to the progression of heart failure.Sensing the cardiac environment: exploiting cues for regenerationCardiotrophin-1: A new predictor of atrial fibrillation relapses after successful cardioversionInjection of Human Cord Blood Cells With Hyaluronan Improves Postinfarction Cardiac Repair in Pigs.Hyaluronan enhances bone marrow cell therapy for myocardial repair after infarctionMyocardial tissue engineering using electrospun nanofiber composites.Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue.Necroptosis, necrostatins and tissue injury.Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration.Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents.Trans-system mechanisms against ischemic myocardial injury.ZnT-1 protects HL-1 cells from simulated ischemia-reperfusion through activation of Ras-ERK signaling.Cardiac regenerative medicine 2.0.Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation?Evaluation of Hydrogels Presenting Extracellular Matrix-Derived Adhesion Peptides and Encapsulating Cardiac Progenitor Cells for Cardiac Repair.Urocortin 2 is associated with abdominal aortic aneurysm and mediates anti-proliferative effects on vascular smooth muscle cells via corticotrophin releasing factor receptor 2.A zinc transporter protects from ischemia-reperfusion injury.Biomaterial property-controlled stem cell fates for cardiac regeneration.Treatment with placental growth factor attenuates myocardial ischemia/reperfusion injury
P2860
Q26824672-B95F6D63-B653-40AC-A198-945073888D73Q33605260-1A92400F-C25A-4625-96BD-24024BAC96D8Q35050037-C7420B20-2391-4807-A414-243BAACF7906Q35068789-4D35D52B-9718-42B1-A386-DF443687082CQ35582221-9BBD198E-C88C-4E93-9A76-D5034766C933Q35906866-C7CC35B7-1D41-41B6-8C56-F99996EF1965Q36123167-C14A6852-C57C-41A4-B42F-FEDFEE88C9D6Q36440749-A962B000-9AA0-4B9B-9593-B21EFAF07191Q36659304-75B6D86D-B29A-4F9F-A231-93B548FEBA19Q37021894-0559A470-3B06-4ACD-AFDF-3516756E1158Q37199307-C2AE2233-A03E-474C-B9AC-436694B13E92Q37874707-9FDDE473-5D34-4CB2-90A2-A6EA8C201B01Q37885482-2821C167-C235-4D65-B978-4C084AB03D9FQ38182522-EBD611BE-53EA-4F42-B40A-075D9C6504D8Q38318626-742145F9-1ACF-4C95-AE63-76F2294E3C67Q39423676-C0AA70DC-C618-437D-BB40-C5EEC3B17F20Q46785597-0FAEF432-38C2-41A3-A4FB-531947B84943Q48266257-2491C9EF-89CD-46D1-8903-109DF5650DD7Q49864665-A03AACBF-2266-47CA-B92F-66DA8D1B9B2AQ53087392-43B0B62E-93AE-4C90-99EC-DF8C11EF2350Q54534233-3ED8C430-539E-4FF4-93D4-5697725A7905Q55066749-8F6FFF93-BE0F-4388-9DA7-C55A2102D21FQ58744453-312EB8B7-DA98-4ABC-8AA7-33F409799C1E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardioprotective growth factors.
@en
Cardioprotective growth factors.
@nl
type
label
Cardioprotective growth factors.
@en
Cardioprotective growth factors.
@nl
prefLabel
Cardioprotective growth factors.
@en
Cardioprotective growth factors.
@nl
P2860
P356
P1476
Cardioprotective growth factors.
@en
P2860
P304
P356
10.1093/CVR/CVP062
P577
2009-02-13T00:00:00Z